X0306 4 2021-03-15 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2021-03-15 4 M 0 10000 20.93 A 10000 D Common Stock 2021-03-15 4 M 0 34 14.22 A 10034 D Common Stock 2021-03-15 4 S 0 411 136.00 D 9623 D Common Stock 2021-03-15 4 S 0 801 137.00 D 8822 D Common Stock 2021-03-15 4 S 0 602 138.26 D 8220 D Common Stock 2021-03-15 4 S 0 300 139.09 D 7920 D Common Stock 2021-03-15 4 S 0 1874 140.38 D 6046 D Common Stock 2021-03-15 4 S 0 2988 141.31 D 3058 D Common Stock 2021-03-15 4 S 0 2101 142.17 D 957 D Common Stock 2021-03-15 4 S 0 957 143.09 D 0 D Stock Option (Right to Buy) 20.93 2021-03-15 4 M 0 10000 0 D 2029-03-08 Common Stock 10000 170798 D Stock Option (Right to Buy) 14.22 2021-03-15 4 M 0 34 0 D 2028-02-28 Common Stock 34 40141 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.47 to $136.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.61 to $137.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.71 to $138.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.78 to $139.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.81 to $140.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.82 to $141.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.85 to $142.78. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.87 to $143.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in 12 equal quarterly installments thereafter. 25% of this option vested and became exercisable on February 27, 2019 with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Brian Sandstrom, as Attorney-in-Fact 2021-03-16